
Uma Borate/na.eventscloud.com
Apr 19, 2025, 07:24
Uma Borate: The Development of Menin Inhibitors in MLL-Rearranged Leukemia
Uma Borate, Acute Leukemia Clinical Section Head and Research Director at James Cancer Hospital shared a post on X:
“What an honour to hear Scott Armstrong talk about the menin inhibitor development story in MLL, NU98 and NPM1 gene rearranged leukemias (list continues to grow) and menin resistance which inevitably follows.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 13:43
Apr 19, 2025, 13:05